Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor

Sushant K. Kachhap, Nadine Rosmus, Spencer J. Collis et al. · 2010

Read Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor by Sushant K. Kachhap, Nadine Rosmus, Spencer J. Collis et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011208.txt.

Description

Kachhap, Rosmus, Collis and colleagues studied prostate cancer drugs in PLOS ONE in 2010. A class of drugs loosens packed DNA, changing which genes are active. The team found these drugs also switch off genes that repair broken DNA by copying from a matching strand.

The shutdown ran through a single gene control factor. Turning off repair leaves cancer cells less able to survive DNA damage. That gives a clear logic for pairing these drugs with DNA damaging treatments. Such pairs could hit prostate tumors harder than either drug alone, a strategy now open to testing.

Catalog record

CREATORSushant K. Kachhap, Nadine Rosmus, Spencer J. Collis et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE53 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011208

Browse the full library · About the Tower of Babel